Bulgaria's lack of cancer biomarker funding prompts discrimination complaint | Euractiv

Patient groups argue that the absence of publicly funded biomarker testing is excluding those unable to pay for access to life-saving personalised cancer therapies

Raccontata daeuractiv.com